A federal appeals court appears skeptical of Biden administration arguments given on May 17 that a lower court ruling overturning a decades-old U.S. Food and Drug Administration (FDA) approval of abortion pill mifepristone was wrongly decided.
The case is one of many that have followed in the wake of the Supreme Court’s decision in June 2022 in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade and found there was no right to abortion in the U.S. Constitution. The ruling returned the regulation of abortion to the states.
